RAF, MEK, and EGFR Inhibitor Dosing in Colorectal Cancer RAF, MEK, and EGFR Inhibitor Dosing in Colorectal Cancer

This case describes toxicities associated with different dose levels of dabrafenib, trametinib, and panitumumab in a patient with BRAF V600E colorectal cancer.JCO Precision Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news